Cargando…
Prognostic value of granulocyte colony-stimulating factor in patients with non-metastatic clear cell renal cell carcinoma
Granulocyte colony-stimulating factor is a well-known cytokine to stimulate inflammatory cells. We sought to investigate the prognostic value of its expression in patients with non-metastatic clear cell renal cell carcinoma. Enrolled in this study were 228 eligible patients treated with curative nep...
Autores principales: | Liu, Zheng, Zhu, Yu, Wang, Yiwei, Fu, Qiang, Fu, Hangcheng, Wang, Zewei, Zhang, Junyu, Li, Gaoxiang, Xu, Jiejie, Dai, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642530/ https://www.ncbi.nlm.nih.gov/pubmed/29050255 http://dx.doi.org/10.18632/oncotarget.19540 |
Ejemplares similares
-
High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patients
por: Fu, Hangcheng, et al.
Publicado: (2016) -
Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma
por: Chang, Yuan, et al.
Publicado: (2016) -
Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma
por: Xie, Huyang, et al.
Publicado: (2016) -
CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma
por: Wang, Zewei, et al.
Publicado: (2016) -
A three-molecule score based on Notch pathway predicts poor prognosis in non-metastasis clear cell renal cell carcinoma
por: Liu, Zheng, et al.
Publicado: (2016)